BTIG Maintains Buy on CareDx, Raises Price Target to $60
CareDx, Inc.
CareDx, Inc. CDNA | 0.00 |
BTIG analyst Mark Massaro maintains CareDx (NASDAQ:
CDNA) with a Buy and raises the price target from $45 to $60.
BTIG Maintains Buy on CareDx, Raises Price Target to $60
CareDx, Inc. CDNA | 0.00 |